New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Prep: Cook: Serves:

Shot of a doctor showing a patient some information on a digital tablet

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed.

Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations.

Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.”

Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we are excited for the role that pharmacists play in this process.”

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Billy Connolly: “Parkinson’s is the first thing I think about in the morning”

Scottish comedian opens up about his Parkinson’s awards ceremony

Michael J Fox Foundation Tour de Fox Series 2016

Registration for the Team Fox summer 2016 cycle series now open

Are you in a patient-style ‘rut’? How to talk so your doctor listens

How to recognise patient styles to improve doctor relationships

Improving access to Parkinson’s disease resources on Amazon’s Alexa

US non-profit Parkinson’s Foundation has announced a new partnership with Amazon’s smart speaker Alexa to help more people access resources related to Parkinson’s disease. As part of the collaboration, Alexa-enabled devices will answer questions about Parkinson’s disease in English and Spanish, citing sources from the Parkinson’s Foundation. The educational initiative is aimed at people with the condition, their care partners, family and friends and health professionals – and will help them find information on topics including Covid-19 and Parkinson’s, symptoms and early signs of the condition, and more. John L Lehr, president and CEO of the Parkinson’s Foundation, said: “We are thrilled to work with Amazon to move into this exciting world of smart speakers to help even more people gain access to the information about Parkinson’s disease they need most. Our hope is that this partnership will help us further reach and better support the Parkinson’s disease community throughout every…

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Billy Connolly: “Parkinson’s is the first thing I think about in the morning”

Global update

Michael J Fox Foundation Tour de Fox Series 2016

PD in Practice

Are you in a patient-style ‘rut’? How to talk so your doctor listens

Improving access to Parkinson’s disease resources on Amazon’s Alexa

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

{title}

Subscribe

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Billy Connolly: “Parkinson’s is the first thing I think about in the morning”

Global update

Michael J Fox Foundation Tour de Fox Series 2016

PD in Practice

Are you in a patient-style ‘rut’? How to talk so your doctor listens

Improving access to Parkinson’s disease resources on Amazon’s Alexa

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

{title}

Subscribe

Sign in